Mycophenolat Mofetil Sandoz (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycophenolat Mofetil Sandoz, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent rejection of transplanted organs such as kidney, heart and liver in transplant recipients. GNH USA supplies Mycophenolat Mofetil Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is used in the management of immune‑mediated processes that can lead to organ rejection. - Kidney transplant rejection: helps maintain graft function by suppressing lymphocyte activity. - Heart transplant rejection: reduces the risk of acute and chronic rejection episodes. - Liver transplant rejection: supports long‑term graft survival by inhibiting immune proliferation.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, may lead to dehydration. - Vomiting: occasional episodes, especially early in treatment. - Abdominal pain: cramping or discomfort. - Headache: transient, often resolves with continued use. - Infections: increased susceptibility to bacterial, viral or fungal infections.

Serious or Rare Side Effects: - Bone marrow suppression: leukopenia, anemia, thrombocytopenia. - Severe infections: opportunistic infections such as CMV or PCP. - Malignancy: increased risk of lymphoproliferative disorders. - Liver toxicity: elevated transaminases or hepatitis. - Progressive multifocal leukoencephalopathy (PML): rare demyelinating disease. - Reproductive toxicity: potential teratogenic effects.

Patients receiving Mycophenolate Mofetil should be monitored closely for safety concerns. - Monitor blood counts: regular CBC to detect bone‑marrow suppression. - Assess renal function: check serum creatinine and eGFR periodically. - Evaluate liver enzymes: monitor ALT, AST for hepatic injury. - Avoid live vaccines: increased risk of vaccine‑derived infection. - Pregnancy risk: discuss contraception and potential fetal effects with a specialist. - Store at room temperature: keep in the original container, protect from moisture and light.

Mycophenolate Mofetil may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Live vaccines: heightened risk of infection. - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): increase mycophenolate exposure.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may worsen renal impairment. - NSAIDs: combined use can affect kidney function. - Antacids or cholestyramine: may reduce oral absorption of mycophenolate.